Jonathan Hersch

2PUBLICATIONS
14CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Dec 26, 2024
A Phase 1b study of the OxPhos inhibitor ME-344 with bevacizumab in refractory metastatic colorectal cancer.

Patrick M Boland, Heinz-Josef Lenz, Kristen K Ciombor

|Jan 12, 2020
Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal Tumors.

Anna M Varghese, Dana B Cardin, Jonathan Hersch

Pageof 1